BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4201536)

  • 1. [Effect of 2-Br-alpha-ergocryptine (CB 154) on the secretion of prolactin in Anguilla].
    Olivereau M; Lemoine AM
    C R Acad Hebd Seances Acad Sci D; 1973 Mar; 276(12):1883-6. PubMed ID: 4201536
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of L-Dopa on the secretion of prolactin in eels].
    Olivereau M; Lemoine AM
    C R Acad Hebd Seances Acad Sci D; 1973 Feb; 276(8):1325-7. PubMed ID: 4196300
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition by 2-Br alpha-ergocryptine-mesilate (CB-154) of suckling-induced pituitary prolactin depletion in lactating rats.
    Flückiger E; Kovacs E
    Experientia; 1974 Oct; 30(10):1173. PubMed ID: 4435126
    [No Abstract]   [Full Text] [Related]  

  • 4. Direct inhibition of pituitary LH secretion in rats by CB-154 (2-Br-alpha-ergocryptine).
    Seki M; Seki K; Yoshihara T; Watanabe N; Okumura T
    Endocrinology; 1974 Mar; 94(3):911-4. PubMed ID: 4591828
    [No Abstract]   [Full Text] [Related]  

  • 5. [Inhibition of prolactin secretion by ergocornine and 2-Br-alpha-ergocryptine: direct action on the hypophysis in culture].
    Pasteels JL; Danguy A; Frérotte M; Ectors F
    Ann Endocrinol (Paris); 1971; 32(1):188-92. PubMed ID: 5556257
    [No Abstract]   [Full Text] [Related]  

  • 6. DNA synthesis and the secretion of prolactin and growth hormone by the pituitary gland of the male rat: effects of diethylstilboestrol and 2-bromo-alpha-ergocryptine methanesluphonate.
    Davies C; Jacobi J; Lloyd HM; Meares JD
    J Endocrinol; 1974 Jun; 61(3):411-7. PubMed ID: 4366118
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of 2-Br-alpha-ergocryptine on pituitary synthesis and release of prolactin and growth hormone in rats.
    Yanai R; Nagasawa H
    Horm Res; 1974 Jan; 5(1):1-5. PubMed ID: 4810405
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of 2-Br- -ergocryptine on fresh water survival in the teleosts, Xiphophorus hellerii and Poecilia latipinna.
    McKeown BA
    Experientia; 1972 Jun; 28(6):675-6. PubMed ID: 5045169
    [No Abstract]   [Full Text] [Related]  

  • 9. The inhibition of prolactin secretion in man by CB-154 (2-Br-alpha-ergocryptine).
    Del Pozo E; Del Re RB; Varga L; Friesen H
    J Clin Endocrinol Metab; 1972 Nov; 35(5):768-71. PubMed ID: 4672297
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of 2-Br-alpha-Ergocryptine, L-dopa and cyclic imides on serum prolactin in postmenopausal women.
    Rozencweig M; Heuson JC; Bila S; L'Hermite M; Robyn C
    Eur J Cancer (1965); 1973 Sep; 9(9):657-64. PubMed ID: 4803232
    [No Abstract]   [Full Text] [Related]  

  • 11. Bovine serum prolactin, growth hormone, cortisol and milk yield after ergocryptine.
    Smith VG; Beck TW; Convey EM; Tucker HA
    Neuroendocrinology; 1974; 15(3-4):172-81. PubMed ID: 4472947
    [No Abstract]   [Full Text] [Related]  

  • 12. Proceedings: Effects of inhibition of prolactin secretion by 2-Br-alpha-ergocryptine at parturition and during lactation in dairy cows.
    Fell LR; Chandler NJ; Goding JR
    J Reprod Fertil; 1974 Feb; 36(2):480-1. PubMed ID: 4819349
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of cyclic gonadotropin secretion by endogenous human prolactin.
    Tyson JE; Khojandi M; Huth J; Smith B; Thomas P
    Am J Obstet Gynecol; 1975 Feb; 121(3):375-9. PubMed ID: 1115151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of 2-Br-alpha-ergokryptine-mesilate (CB 154) on the pituitary prolactin content of prooestrus rats.
    Kovacs E; Flückiger E
    Experientia; 1974 Oct; 30(10):1172. PubMed ID: 4474088
    [No Abstract]   [Full Text] [Related]  

  • 15. Two-bromo- -ergocryptine (CB 154) inhibition of prolactin secretion and galactorrhoea in a case of pituitary tumour.
    Copinschi G; L'Hermite M; Pasteels JL; Robyn C
    Gynecol Invest; 1971; 2(1):128-9. PubMed ID: 5170651
    [No Abstract]   [Full Text] [Related]  

  • 16. Endocrine profile of a specific prolactin inhibitor: Br-ergocryptine (CB 154). A preliminary report.
    Del Pozo E; Friesen H; Burmeister P
    Schweiz Med Wochenschr; 1973 Jun; 103(23):847-8. PubMed ID: 4351250
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of DMBA-induced mammary carcinogenesis in the rat by 2-br- -ergocryptine (CB 154), an inhibitor of prolactin secretion, and by nafoxidine (U-11, 100 A), an estrogen antagonist.
    Heuson JC; Waelbroeck C; Legros N; Gallez G; Robyn C; L'Hermite M
    Gynecol Invest; 1971; 2(1):130-7. PubMed ID: 5170652
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of 2-BR-alpha-ergokryptine (CB 154) on sex-linked rejection of pituitary isografts in female C57BL mice.
    Hoshino K
    Experientia; 1973; 29(7):882-4. PubMed ID: 4146807
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of thyrotropin and prolactin secretions in primary hypothyroidism by 2-Br-alpha-ergocryptine.
    Miyal K; Onishi T; Hosokawa M; Ishibashi K; Kumahara Y
    J Clin Endocrinol Metab; 1974 Aug; 39(2):391-4. PubMed ID: 4418165
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of ergocornine and 2-Br-alpha-ergokryptin (CB-154) on the formation of mammary hyperplastic alveolar nodules and the pituitary prolactin levels in mice.
    Yanai R; Nagasawa H
    Experientia; 1970 Jun; 26(6):649-50. PubMed ID: 5424352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.